Select the optimal device size and implant position using unmatched predictive simulation.
≈
FEops HEARTguide™ is a unique, stand-alone solution. It combines predictive simulation with AI-based anatomical measurements to deliver results that are easy to integrate into a clinical workflow.
≈
≈
LAAO - Multiplanar Reconstruction (MPR)
The new version of FEops HEARTguide™ – now with DICOM interface – has been developed for fast and accurate anatomical analysis. It includes semi-automatic identification and measurement of anatomical landmarks. The DICOM interface allows cardiologists, medical care providers, researchers, and others to easily conduct a full review of a patient’s anatomical landmarks.
TAVI - MPR
Key benefits:
LAAO - Anatomical analysis
All the necessary tools close at hand
FEops HEARTguide™ provides general functionalities such as:
– Segmentation of cardiovascular structures.
– Visualization and image reconstruction techniques: 2D review and MPR.
– Tools for taking measurements and making annotations.
TAVI - Anatomical analysis
FEops HEARTguide™ is a procedure planning platform that has been specifically developed for interventional cardiologists. It enables them to plan percutaneous procedures quickly and accurately. Multiple workflows have been developed to suit different situations.
FEops HEARTguide, cloud-based planning platform, offers secure access from anywhere at any time to automated anatomical analysis and predictive planning for Structural Heart interventions. This new release gives you now the possibility to grant secure access to other FEops HEARTguide users outside your organization, for one or multiple of your cases. This new feature will make it easier and secure your case sharing with peers and industry partners and transforms FEops HEARTguide into a unique collaborative platform.
Case(s) sharing
Key benefits:
(*) option to revoke access at any time.
Predictive simulations
Abbott Amplatzer™ Amulet™
Get unique insights and make LAAO procedures more predictable with FEops HEARTguide™
FEops HEARTguide™ enables a clear assessment of a patient’s anatomy. The software provides a segmentation of the left side of the heart with semi-automatic identification and measurement of anatomical landmarks. The 3D Model can be rotated to enable detailed assessment of left atrial appendage (LAA) morphology. It is also possible to evaluate different device sizes and positioning options using predicted device apposition, frame deformation and compression rate of the simulated LAA occluder. And physicians can select the optimal device size and implant position for a patient by using predictive simulation to see how a specific LAA occluder will interact with that patient’s unique anatomy.
Predictive simulations
Boston Scientific WATCHMAN FLX™
Key benefits:
- Predict device apposition, frame deformation and compression rate.
- Select the optimal device size and implant position for a specific patient.
- C-arm angulation with pre-defined views: optimal projection and lateral-apical for TSP guidance.
- Improve procedural success rates by using one device and one deployment¹
¹ PREDICT-LAA , J Am Coll Cardiol Intv. Feb 22, 2023. Epublished DOI: 10.1016/j.jcin.2023.01.008
Medtronic Evolut™ PRO+
Plan even your most challenging TAVI cases with confidence
FEops HEARTguide™ lets physicians accurately predict which patients are at risk for new pacemakers or paravalvular leaks via aortic root assessment and patient-specific digital simulations. It enables them to select the best size and position of valve for a specific patient. It also allows for better assessment of implant depth with precise and predictive simulations for different device sizes, including data-driven insights such as frame deformation, displacement of leaflet calcification, and paravalvular-leak predictions.
Boston Scientific ACURATE neo2™
Key benefits
- Assess potential complications for different device sizes and positions.
- Accurately predict which patients are at risk for new pacemakers or paravalvular leaks.²
- Most appropriate treatment modality for patients with Bicuspid Aortic Valve (BAV) .³
- Select proper angulation with pre-defined views: “Cusp Overlap” view and “Three-cusp” view.
²Hokken T. - Van Mieghem N. et al. Computed Tomography-Derived Predictive Simulations of Transcatheter Aortic Valve Replacement in Challenging Anatomies. CRT-700.26 JACC Cardiovascular Interventions, February 2022
³Dowling C. et al, Ongoing experience with patient-specific computer simulation of transcatheter aortic valve replacement in bicuspid aortic valve. https://doi.org/10.1016/j.carrev.2023.01.015. CardiovascularRevascularizationMedicine, In Press, Jan 2023
Neo-left ventricle outflow tract (neo-LVOT) assessment
● Early research² supports the use of FEops simulation technology in transcatheter mitral valve replacement (TMVR).
● FEops HEARTguide provides a finite element simulation based on segmentation of the CT scan. This enables it to calculate the neo-LVOT area at various heights of deployment.
Transcatheter mitral valve replacement in mitral annulus calcification (MAC)
● Computer simulation may have the potential to improve patient selection for transcatheter mitral valve replacement in the presence of significant MAC.³
¹FEops HEARTguide is currently not indicated for clinical use in TMVR
²Chehab et al, JACC State-of-the-Art Review VOL. 80, NO. 7, 2022 Management of Patients With Severe Mitral Annular Calcification
³Karady J, et al, JCCT ref 1052 DOI: 10.1016/j.jcct.2017.12.007Transcatheter mitral valve replacement in mitral annulus calcification – “The art of computer simulation”
*In EU, UK, Canada and Australia, FEops HEARTguide™ is available for AI-enabled anatomical analysis and computer simulation with indication for use in TAVI and LAAO. In USA, FEops HEARTguide ™ is available for AI-enabled anatomical analysis with indication for use in TAVI and LAAO and for computer simulation in LAAo with WATCHMAN™, WATCHMAN™FLX, Amplatzer™ Amulet™.
**FEops HEARTguide is currently not indicated for clinical use in TMVR